PRVB
Principal Financial Group’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-306,298
| Closed | -$7.38M | – | 2556 |
|
|
2023
Q1 | $7.38M | Buy |
306,298
+67,225
| +28% | +$1.62M | 0.01% | 1396 |
|
|
2022
Q4 | $2.53M | Buy |
239,073
+223,922
| +1,478% | +$2.37M | ﹤0.01% | 1723 |
|
|
2022
Q3 | $68K | Buy |
15,151
+153
| +1% | +$687 | ﹤0.01% | 2387 |
|
|
2022
Q2 | $60K | Buy |
+14,998
| New | +$60K | ﹤0.01% | 2449 |
|
|
2021
Q4 | – | Sell |
-12,587
| Closed | -$81K | – | 2676 |
|
|
2021
Q3 | $81K | Sell |
12,587
-2,043
| -14% | -$13.1K | ﹤0.01% | 2518 |
|
|
2021
Q2 | $123K | Sell |
14,630
-9,192
| -39% | -$77.3K | ﹤0.01% | 2516 |
|
|
2021
Q1 | $250K | Sell |
23,822
-91
| -0.4% | -$955 | ﹤0.01% | 2327 |
|
|
2020
Q4 | $405K | Buy |
+23,913
| New | +$405K | ﹤0.01% | 2169 |
|
|
2020
Q3 | – | Sell |
-10,174
| Closed | -$144K | – | 2370 |
|
|
2020
Q2 | $144K | Buy |
+10,174
| New | +$144K | ﹤0.01% | 2220 |
|